Christopher Cano - Sep 22, 2021 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Signature
/s/ Christopher Cano, by Kirk Allen Coleman, as Attorney-in-Fact
Stock symbol
TFFP
Transactions as of
Sep 22, 2021
Transactions value $
$0
Form type
4
Date filed
9/24/2021, 04:15 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFFP Stock Option (Right to Buy) Award $0 +43K +27.39% $0.00 200K Sep 22, 2021 Common Stock 43K $7.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options are granted under TFF Pharmaceuticals, Inc. 2021 Stock Incentive Plan ("Plan") and the exercise of the Options is subject to stockholder approval of the Plan. Subject to stockholder approval of the Plan, each Option shall vest and first become exercisable as follows: one-quarter of the Option shall vest and first become exercisable on September 22, 2022 and the remainder of the Option shall vest and first become exercisable in 12 equal quarterly installments commencing on December 22, 2022.